PTS Diagnostics Promotes Two, Reorganizes Sales Team
Realignment of domestic sales force supports outcome-based healthcare system
INDIANAPOLIS (Feb. 19, 2019) – PTS Diagnostics, a U.S.-based manufacturer of point-of-care biometric testing devices, today announced that they have established and filled new domestic sales positions.
We are proud to celebrate the following additions to the PTS Diagnostics family:
Ken Kimker and Jennifer Leding are assuming the roles of Directors, Distribution.
Kimker joined PTS Diagnostics in 2015 and Leding in 2016 as Area Sales Managers. Both have distinguished themselves in their abilities to demonstrate the value of point-of-care solutions to ACOs and healthcare systems. In their new roles, they’ll work closely with our national distribution partners and assist with the launch of PreVantage, our new wellness brand.
PTS Diagnostics has also added the positions of Senior Managers, PreVantage Solutions. In addition to tenured members of our U.S. sales organization who are taking on these titles, we’re excited to welcome Jason Edwards, Michael Kraus, and Jeff Robertson.
These individuals come to us with extensive knowledge of healthcare reimbursement and are experienced solution sellers. We’re excited to utilize these new positions in order to further grow the PreVantage brand in numerous verticals.
“The continued evolution of our sales force aligns with our organizational philosophy of expanding upon the markets we serve in order to reach as many individuals afflicted with cardiometabolic conditions as possible,” said Cliffe Allen, Vice President, U.S. Sales, at PTS Diagnostics. “These new roles are essential to impacting those most affected by shifts in healthcare such as MIPS and MACRA. We’re excited to watch these individuals grow and thrive.”
This realignment precedes the move to a new global headquarters in Whitestown, Ind. which is anticipated to open in spring of 2019.
About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-ofcare medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 140 countries around the globe. For more information, visit ptsdiagnostics.com.